HCP Live

Articles by HCP Live

Reluctance in Getting Vaccinated to Prevent Coronavirus

ByHCP Live

July 27th 2020

Vaccine Development to Protect Against Coronavirus

ByHCP Live

July 27th 2020

Effect of Viral Mutations on the Spread and Severity of COVID-19

ByHCP Live

July 27th 2020

Lack of Herd Immunity to COVID-19

ByHCP Live

July 27th 2020

Risk Factors Causing Complications Due to COVID-19

ByHCP Live

July 27th 2020

Developing Treatments for Pediatric Atopic Dermatitis

ByHCP Live

July 24th 2020

Monoclonal Antibody Toxicity Profile and Patient Impact

ByHCP Live

July 24th 2020

Monoclonal Antibody FDA Approval for Pediatric Population

ByHCP Live

July 24th 2020

Pediatric AD: Differential Diagnosis and Tools

ByHCP Live

July 24th 2020

Atopic Dermatitis Pathophysiology

ByHCP Live

July 24th 2020

The Shifting Treatment Paradigm in AD Management

ByHCP Live

July 24th 2020

First-Line Biologics for Pediatric AD and Psoriasis

ByHCP Live

July 24th 2020

Topical Therapy Approach for Pediatric Atopic Dermatitis

ByHCP Live

July 24th 2020

Monoclonal Antibody Prior Authorization

ByHCP Live

July 24th 2020

Monoclonal Antibody Therapy for Pediatrics With AD

ByHCP Live

July 24th 2020

Moderate to Severe Disease: Systemic Therapy

ByHCP Live

July 24th 2020

Pediatric AD: State-of-the-Art Treatment

ByHCP Live

July 24th 2020

Nonpharmacological Approach to Managing Atopic Dermatitis

ByHCP Live

July 24th 2020

Seeking Care for Atopic Dermatitis

ByHCP Live

July 24th 2020

Presentation and Severity of Atopic Dermatitis

ByHCP Live

July 24th 2020

Impact of Atopic Dermatitis: Pediatrics Versus Adults

ByHCP Live

July 24th 2020

Atopic Dermatitis: Age of Onset and Prevalence

ByHCP Live

July 24th 2020

Managing Inflammatory Bowel Diseases in the Community

ByHCP Live

June 25th 2020

Role of Specialty Pharmacy in IBD Management

ByHCP Live

June 25th 2020

Treatment Challenges in IBD

ByHCP Live

June 25th 2020

Novel Therapies in the IBD Pipeline

ByHCP Live

June 25th 2020

Optimizing Outcomes When Switching Biologics in IBD

ByHCP Live

June 25th 2020

Switching Between Biologics for IBD

ByHCP Live

June 25th 2020

Inflammatory Bowel Disease Treatment Selection

ByHCP Live

June 25th 2020

Implications of the GEMINI Trial in IBD

ByHCP Live

June 25th 2020

HCP Live

Articles by HCP Live

Reluctance in Getting Vaccinated to Prevent Coronavirus

Vaccine Development to Protect Against Coronavirus

Effect of Viral Mutations on the Spread and Severity of COVID-19

Lack of Herd Immunity to COVID-19

Risk Factors Causing Complications Due to COVID-19

Developing Treatments for Pediatric Atopic Dermatitis

Monoclonal Antibody Toxicity Profile and Patient Impact

Monoclonal Antibody FDA Approval for Pediatric Population

Pediatric AD: Differential Diagnosis and Tools

Atopic Dermatitis Pathophysiology

The Shifting Treatment Paradigm in AD Management

First-Line Biologics for Pediatric AD and Psoriasis

Topical Therapy Approach for Pediatric Atopic Dermatitis

Monoclonal Antibody Prior Authorization

Monoclonal Antibody Therapy for Pediatrics With AD

Moderate to Severe Disease: Systemic Therapy

Pediatric AD: State-of-the-Art Treatment

Nonpharmacological Approach to Managing Atopic Dermatitis

Seeking Care for Atopic Dermatitis

Presentation and Severity of Atopic Dermatitis

Impact of Atopic Dermatitis: Pediatrics Versus Adults

Atopic Dermatitis: Age of Onset and Prevalence

Managing Inflammatory Bowel Diseases in the Community

Role of Specialty Pharmacy in IBD Management

Treatment Challenges in IBD

Novel Therapies in the IBD Pipeline

Optimizing Outcomes When Switching Biologics in IBD

Switching Between Biologics for IBD

Inflammatory Bowel Disease Treatment Selection

Implications of the GEMINI Trial in IBD

Trending on HCPLive

Bringing Bronchiectasis Guidelines Into Everyday Practice

The Future of Bronchiectasis Care: Precision Medicine Ahead

Does Artificial Intelligence Worsen Health Care Disparities?

Sequencing Therapies for Bronchiectasis: A Practical Approach

Inhaled Antibiotics for Pseudomonas in Bronchiectasis